Considering the situation of fast increasing infected patients, since the early of March, CP has been recommended for emergent use in treating severe COVID-19 patients in the most countries of the world (Chen and Xia, 2020; Mahase, 2020; Shen et al., 2020). The gene discussed is CP; the disease is COVID-19.